Nicotinamide Cooperates with Retinoic Acid and 1,25-Dihydroxyvitamin D3 to Regulate Cell Differentiation and Cell Cycle Arrest of Human Myeloblastic Leukemia Cells
- 6 January 2009
- journal article
- research article
- Published by S. Karger AG in Oncology
- Vol. 76 (2), 91-100
- https://doi.org/10.1159/000188664
Abstract
Nicotinamide, the amide derivative of vitamin B3, cooperates with retinoic acid (RA), a form of vitamin A, and 1,25-dihydroxyvitamin D3 (D3), to regulate cell differentiation and proliferation of human myeloblastic leukemia cells. In human myeloblastic leukemia cells, RA or D3 are known to cause MAPK signaling leading to myeloid or monocytic differentiation and G0 cell cycle arrest. In this process, RA or D3 induces the early expression of CD38, a receptor that causes ERK signaling and propels further differentiation. Our study demonstrates that nicotinamide in combination with RA or D3 affected induced expression levels of CD38, CD11b and CD14, suggesting a cooperative function of nicotinamide and RA or D3. Nicotinamide transiently retarded the initial RA- or D3-induced expression of CD38, which subsequently reached the same nearly 100% expression. Nicotinamide induced ERK activation and further enhanced the RA-induced ERK activation, but the D3-induced ERK activation was diminished by nicotinamide, although levels still exceeded those induced by RA, suggesting lineage-specific nicotinamide responses. Nicotinamide enhanced both RA- and D3-induced CD11b expression, inducible oxidative metabolism, and G0 cell cycle arrest, accelerating their induced occurrence in all instances. Consistent with this, the RA- or D3-induced downregulation of PARP was enhanced by nicotinamide. Nicotinamide thus regulated RA- or D3-induced differentiation and G0 arrest, causing a transient delay in certain early aspects of the progression to terminal differentiation but ultimately accelerating the occurrence of terminally, functionally differentiated G0 cells.This publication has 46 references indexed in Scilit:
- The Role of Platelet/Endothelial Cell Adhesion Molecule–1 (CD31) and CD38 Antigens in Marrow Microenvironmental Retention of Acute Myelogenous Leukemia CellsCancer Research, 2007
- Nicotinamide abrogates acute lung injury caused by ischaemia/reperfusionEuropean Respiratory Journal, 2007
- Effects of Histone Deacetylase Inhibitors, Sodium Phenyl Butyrate and Vitamin B3, in Combination with Retinoic Acid on Granulocytic Differentiation of Human Promyelocytic Leukemia HL‐60 CellsAnnals of the New York Academy of Sciences, 2006
- The CD38/CD157 mammalian gene family: An evolutionary paradigm for other leukocyte surface enzymesPurinergic Signalling, 2006
- Effect of standard nicotinamide in the prevention of type 1 diabetes in first degree relatives of persons with type 1 diabetesAutoimmunity, 2006
- Retinoic acid‐induced CD38 expression in HL‐60 myeloblastic leukemia cells regulates cell differentiation or viability depending on expression levelsJournal of Cellular Biochemistry, 2005
- PARP-1 Determines Specificity in a Retinoid Signaling Pathway via Direct Modulation of MediatorMolecular Cell, 2005
- Polyomavirus Small t Antigen Prevents Retinoic Acid-Induced Retinoblastoma Protein Hypophosphorylation and Redirects Retinoic Acid-Induced G 0 Arrest and Differentiation to ApoptosisJournal of Virology, 2001
- A Single Protein Immunologically Identified as CD38 Displays NAD+ Glycohydrolase, ADP-Ribosyl Cyclase and Cyclic ADP-Ribose Hydrolase Activities at the Outer Surface of Human ErythrocytesBiochemical and Biophysical Research Communications, 1993
- Structure and Function of Lipopolysaccharide Binding ProteinScience, 1990